Digitisation | February 25, 2025
Amgen opens new technology and innovation site in Hyderabad
Amgen India investment totals $200 million through 2025
Amgen India investment totals $200 million through 2025
Advances Amgen's mission to serve patients with rare disease medicines
This study showed that patients taking 75mg of Olpasiran previously every 12 weeks presented a 40–50% reduction in LP(a)
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
Under the terms of the agreement, Arrakis will lead research activities for the identification of RNA-targeted small molecule (rSM) binders against a broad set of targets nominated by Amgen
Syngene will also build and operate a new dedicated drug development laboratory to accelerate the advancement of Amgen R&D projects
He has successfully led the development of 15 approved drugs worldwide across various therapeutic areas over his more than 20-year career
The FDA also expanded Repatha’s use as monotherapy to include patients with homozygous familial hypercholesterolemia
New findings reveal bemarituzumab plus chemotherapy significantly improves survival in advanced gastric cancer, offering hope for targeted treatment options
Dr. Berger is a board-certified internist, hematologist and oncologist who brings more than 25 years of extensive experience in developing and delivering innovative medicines
Subscribe To Our Newsletter & Stay Updated
